Elanco Animal Health Incorporated : Investor Overview

Published: 2025-05-07 06:47:07 ET ELAN

Published on 05/07/2025 at 06:47

Food and Companionship Enriching Life

Touching nearly every person, every day

Transforming Animal Care

Helping pets live longer, healthier, more active lives.

From diabetes, to the deadliest disease in puppies, parvovirus, and many others

Increased production, reduced emissions

4

Investor Overview | May 2025

Elanco at a Glance

Key Financial Metrics

2024 Results

$4.439 B

Revenue

$910 M

Adj. EBITDA1

$0.91

Adj. EPS1

We provide medicines and services to help

veterinarians, and pet owners

improve care for pets and enable farmers to raise healthier livestock more sustainably

Diverse, Global Portfolio2

5 Core Species

Pet health & farm animals

Dogs, cats, cattle, swine, and poultry

Balanced Portfolio Between pet health and livestock products revenue

9 Blockbusters

>$100M in annual revenue

90+

countries served

200+ brands sold for pets & farm animals

53%

Revenue from outside the U.S.

~9,300 Employees worldwide 16

~1,000

R&D Employees

~2,000

Sales Representatives

Manufacturing sites

1Non-GAAP financial measure. See Appendix to this presentation for more information, including GAAP to non-GAAP reconciliations.

2Facts and figures shown are as of Dec. 31, 2024; excluding contribution from the aqua business which the company divested July 9, 2024.

5

Disclaimer

Elanco Animal Health Inc. published this content on May 07, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 07, 2025 at 10:46 UTC.